Viewing Study NCT07240766


Ignite Creation Date: 2025-12-24 @ 4:32 PM
Ignite Modification Date: 2026-01-07 @ 7:29 PM
Study NCT ID: NCT07240766
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-21
First Post: 2025-11-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation
Sponsor: Zhejiang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module